WallStreetZenWallStreetZen

NASDAQ: DNLI
Denali Therapeutics Inc Stock Ownership - Who owns Denali Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Denali Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Peter Scott ChinMed2026-09-041,654$22.29
$36.87kSell
Nancy ThornberryDirector2026-09-02615$23.74
$14.60kSell
Nancy ThornberryDirector2026-09-0210,824$22.85
$247.33kSell
Alexander O. SchuthSec2026-09-012,768$23.44
$64.88kSell
Alexander O. SchuthSec2026-08-112,857$25.07
$71.62kSell
Alexander O. SchuthCOFO and Secretary2026-01-0617,218$16.50
$284.10kSell
Ryan J. WattsPresident and CEO2026-01-0635,198$16.50
$580.77kSell

1 of 1

DNLI insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when DNLI insiders and whales buy or sell their stock.

DNLI Shareholders

What type of owners hold Denali Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Robert Nelsen12.98%20,749,930$428.90MInsider
Biogen Inc8.33%13,310,243$275.12MInsider
Arch Venture Fund VIII LP6.67%10,668,749$220.52MInsider
Douglas K. Bratton6.31%10,084,938$208.46MInsider
Fmr LLC6.12%9,779,988$202.15MInsider
Flagship Ventures Fund V LP5.58%8,918,749$184.35MInsider
Fil Ltd2.93%4,679,275$96.72MInsider
Ryan J. Watts2.86%4,569,821$94.46MInsider
Baker Bros Advisors LP2.14%3,422,366$70.74MInsider
Marc Tessierlavigne1.33%2,123,445$43.89MInsider

1 of 3

DNLI vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
DNLI0.10%57.28%Net SellingNet Selling
TARS0.11%39.11%Net SellingNet Selling
RCUS0.10%44.15%Net SellingNet Selling
ARQT0.10%30.68%Net SellingNet Selling
ELVN0.11%80.98%Net SellingNet Selling
View Top Biotech Stocks

Denali Therapeutics Stock Ownership FAQ

Who owns Denali Therapeutics?

Denali Therapeutics (NASDAQ: DNLI) is owned by 0.10% institutional shareholders, 57.28% Denali Therapeutics insiders, and 42.62% retail investors. Robert Nelsen is the largest individual Denali Therapeutics shareholder, owning 20.75M shares representing 12.98% of the company. Robert Nelsen's Denali Therapeutics shares are currently valued at $426.00M.

If you're new to stock investing, here's how to buy Denali Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.